Humana said its regular annual meeting of stockholders was held on April 16, 2026 to vote on five proposals, with holders of 107,941,773 shares present by valid proxy, constituting a quorum.

1. 01

   Humana said its regular annual meeting of stockholders was held on April 16, 2026 to vote on five proposals, with holders of 107,941,773 shares present by valid proxy, constituting a quorum.

2. 02

   The company said all 10 director nominees were elected. Wayne A. I. Frederick, M.D. received 85,170,452 votes for, 16,912,783 against and 119,493 abstentions, while Raquel C. Bono, M.D. received 101,247,023 for, 852,333 against and 103,372 abstentions.

3. 03

   The company said its stockholders approved the ratification of PricewaterhouseCoopers LLP as its independent registered public accounting firm for 2026, with 102,433,686 votes for and 5,381,161 against. The advisory vote on executive compensation was approved with 97,237,851 votes for and 4,669,732 against. The Humana Inc. 2026 Stock Incentive Plan was approved with 97,655,200 votes for and 4,295,549 against.

4. 04

   The company said a stockholder proposal requesting shareholder approval for excessive golden parachutes was not approved, with 41,970,892 votes for, 59,079,279 against and 1,152,557 abstentions.

Analysis scope · Filing bodyWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.